Comprehensive Guide to Hydroxyzine: Uses, Dosage, Side Effects, and More

What is Hydroxyzine?

Overview of Hydroxyzine

Generic Name: Hydroxyzine

Brand Name: Atarax, Vistaril, generics

Drug Group: Antihistamine (anxiolytic, sedative)

Commonly Used For

• Treat anxiety and tension.
• Relieve allergic symptoms.
• Aid in short-term insomnia.

Key Characteristics

Form: Oral tablets (10 mg, 25 mg, 50 mg), capsules (25 mg, 50 mg), syrup (10 mg/5 mL), or IM injection (25 mg/mL, 50 mg/mL) (detailed in Dosage section).

Mechanism: Blocks H1 receptors and has anticholinergic effects, reducing anxiety and allergic responses.

Approval: FDA-approved (1956 for Atarax) and EMA-approved for anxiety and allergies.

Indications and Uses of Hydroxyzine

Hydroxyzine is indicated for a variety of psychiatric, allergic, and sleep-related conditions, leveraging its antihistaminic and sedative properties:

Generalized Anxiety Disorder (GAD): Alleviates excessive worry and tension, per psychiatry guidelines, supported by clinical trials showing reduced Hamilton Anxiety Scale scores within 1–2 weeks.

Allergic Reactions: Manages symptoms of urticaria, itching, and rhinitis caused by allergens, recommended in allergy protocols with evidence of histamine suppression.

Insomnia (Short-Term): Promotes sleep onset in transient insomnia, improving sleep latency, with sleep medicine data.

Pruritus: Treats chronic itching from dermatitis or eczema, reducing scratch-induced damage, per dermatology studies.

Nausea and Vomiting: Investigated off-label to control postoperative or chemotherapy-induced nausea, with anesthesiology-oncology evidence.

Pre- and Postoperative Sedation: Used off-label to calm patients before surgery, with surgical medicine research.

Alcohol Withdrawal: Explored off-label to reduce agitation and tremors, with addiction psychiatry data.

Panic Attacks: Managed off-label to mitigate acute panic symptoms, with psychology studies.

Motion Sickness: Initiated off-label to prevent nausea during travel, with travel medicine evidence.

Chronic Pain Adjunct: Applied off-label to enhance pain management with sedatives, with pain medicine research.

Dosage of Hydroxyzine

Dosage for Adults

Anxiety:

• Oral: 50–100 mg up to 4 times daily, not exceeding 400 mg/day.
• IM: 25–100 mg, repeated every 4–6 hours as needed.

Allergic Conditions:

• Oral: 25–100 mg up to 4 times daily, based on symptom severity.
• IM: 25–50 mg every 6–8 hours.

Insomnia:

• Oral: 50–100 mg at bedtime, adjusted for sedation level.

Dosage for Children (≥6 years)

Anxiety or Allergies:

• Oral: 0.5–1 mg/kg/dose every 6 hours, not exceeding 100 mg/day, under pediatric supervision.
• IM: 0.5–1 mg/kg every 6 hours, maximum 100 mg/day.

Dosage for Pregnant Women

Pregnancy Category C: Use only if benefits outweigh risks; consult an obstetrician, with fetal monitoring.

Dosage Adjustments

Renal Impairment: Reduce dose by 50% in severe cases (CrCl <30 mL/min); monitor for accumulation.

Hepatic Impairment:

Mild to moderate (Child-Pugh A or B): Use cautiously with reduced frequency; severe (Child-Pugh C): Avoid.

Concomitant Medications: Adjust if combined with CNS depressants (e.g., alcohol, benzodiazepines), increasing sedation risk; monitor.

Elderly: Start with 10–25 mg, titrate slowly, and monitor for QT prolongation.

Prolonged Use: Limit to short-term (≤4 weeks) unless under specialist care, with ECG monitoring.

Additional Considerations

• Take this active ingredient with or without food, preferably with water to aid swallowing.
• Avoid abrupt discontinuation after prolonged use to prevent withdrawal symptoms.

How to Use Hydroxyzine

Administration:

Oral: Swallow tablets or capsules whole, or measure syrup with a calibrated device.

IM: Inject deep into the muscle (e.g., deltoid or gluteal), using a 1–2 mL syringe.

Timing: Take or administer at consistent intervals, with bedtime dosing for insomnia.

Monitoring: Watch for drowsiness, confusion, or signs of QT prolongation (e.g., irregular heartbeat); report changes immediately.

Additional Tips:

• Store at 20–25°C (68–77°F), protecting from moisture and light.
• Keep out of reach of children due to sedation risk.
• Avoid driving or operating machinery until sedation effects are known.
• Use with a sleep hygiene plan (e.g., dark room, no screens) to enhance insomnia treatment.
• Schedule regular follow-ups every 1–2 weeks to assess sedation, cardiac function, and efficacy.

Contraindications for Hydroxyzine

Hypersensitivity: Patients with a known allergy to Hydroxyzine, cetirizine, or other piperazine derivatives.

Prolonged QT Interval: Contraindicated in patients with known QT prolongation or torsades de pointes history.

Severe Hepatic Impairment: Avoid in Child-Pugh Class C due to metabolism concerns.

Glaucoma: Contraindicated in narrow-angle glaucoma due to anticholinergic effects.

Myasthenia Gravis: Avoid due to worsening muscle weakness.

Concurrent Use with MAOIs: Avoid within 14 days of MAOI therapy due to serotonin syndrome risk.

Warnings & Precautions for Hydroxyzine

General Warnings

QT Prolongation: Risk of arrhythmias; monitor ECG in patients with cardiac risk factors.

Sedation: Risk of excessive drowsiness; avoid alcohol or CNS depressants.

Anticholinergic Effects: Risk of dry mouth, constipation, or urinary retention; monitor elderly patients.

Seizure Risk: Rare exacerbation; discontinue if seizures occur.

Hypotension: Risk with rapid IV use (not recommended); monitor blood pressure.

Additional Warnings

Dementia Aggravation: Risk in elderly with cognitive impairment; use cautiously.

Allergic Reactions: Rare anaphylaxis; stop if severe.

Respiratory Depression: Risk in patients with COPD or sleep apnea; monitor breathing.

Paradoxical Excitation: Rare in children; assess behavior changes.

Hypersensitivity Reactions: Rare angioedema; discontinue if swelling occurs.

Use in Specific Populations

Pregnancy: Category C; use with caution and monitoring.

Breastfeeding: Contraindicated; avoid due to potential sedation in infants.

Elderly: Higher risk of anticholinergic effects and QT prolongation; start low and monitor.

Children: Safe for short-term use with supervision.

Renal/Hepatic Impairment: Adjust or avoid in severe cases.

Additional Precautions

• Inform your doctor about heart disease, glaucoma, or medication allergies before starting this medication.
• Avoid abrupt cessation after prolonged use to prevent rebound anxiety or insomnia.

Overdose and Management of Hydroxyzine

Overdose Symptoms

Drowsiness, dry mouth, or tachycardia.

Severe cases: Seizures, QT prolongation, or respiratory depression.

Confusion, hallucinations, or tremor as early signs.

Coma or cardiac arrest with extremely high doses.

Immediate Actions

Contact the Medical Team: Seek immediate medical help.

Supportive Care: Monitor vital signs, provide oxygen, and manage seizures with benzodiazepines if needed.

Specific Treatment: No specific antidote; use physostigmine for anticholinergic overdose under specialist guidance.

Monitor: Check ECG, respiratory rate, and mental status for 24–48 hours.

Patient Education: Advise against self-adjusting doses and to store safely.

Additional Notes

• Overdose risk is significant with misuse; store securely and limit access.
• Report persistent symptoms (e.g., irregular heartbeat, severe drowsiness) promptly.

Side Effects of Hydroxyzine

Common Side Effects

• Drowsiness (20–30%, decreases with time)
• Dry Mouth (10–20%, managed with hydration)
• Dizziness (5–15%, reduced with rest)
• Headache (5–10%, relieved with analgesics)
• Constipation (3–8%, managed with fiber)

These effects may subside with adaptation.

Serious Side Effects

Additional Notes

Regular monitoring with ECG (baseline and weekly) is advised for patients on prolonged therapy (>2 weeks) to detect QT changes.

Patients with a history of epilepsy should be closely watched, with anticonvulsant backup considered.

Report any unusual symptoms (e.g., chest pain, difficulty breathing) immediately to a healthcare provider.

Long-term use (>4 weeks) requires liver function tests and cognitive assessments to monitor for rare hepatic or neurological effects.

Drug Interactions with Hydroxyzine

This active ingredient may interact with:

• CNS Depressants: Increases sedation (e.g., alcohol, opioids); avoid combination.
• QT-Prolonging Drugs: Enhances arrhythmia risk (e.g., amiodarone); monitor ECG.
• Anticholinergics: Potentiates effects (e.g., atropine); monitor for confusion.
• MAOIs: Increases serotonin syndrome risk; avoid within 14 days.
• CYP3A4 Inhibitors: Raises levels (e.g., ketoconazole); adjust dose.

Action: Provide your healthcare provider with a complete list of medications.

Patient Education or Lifestyle

Pharmacokinetics of Hydroxyzine

Absorption: Oral, peak at 2 hours; IM peak at 30 minutes; bioavailability ~80%.

Distribution: Volume of distribution ~16 L/kg; 93% protein-bound.

Metabolism: Hepatic via CYP3A4/2D6 to cetirizine and other metabolites.

Excretion: Primarily renal (as metabolites); half-life 20 hours.

Half-Life: 20 hours, prolonged in hepatic impairment.

Pharmacodynamics of Hydroxyzine

This drug exerts its effects by:

Blocking H1 receptors, reducing allergic and pruritic symptoms.

Inhibiting serotonin and acetylcholine activity, promoting anxiolysis and sedation.

Exhibiting dose-dependent risks of QT prolongation and anticholinergic effects.

Storage of Hydroxyzine

Temperature: Store at 20–25°C (68–77°F); protect from moisture and light.

Protection: Keep in original container, away from heat and humidity.

Safety: Store in a secure location out of reach of children and pets due to sedation risk.

Disposal: Dispose of unused tablets, syrup, or vials per local regulations or consult a pharmacist.

Frequently Asked Questions (FAQs)

Q: What does Hydroxyzine treat?
A: This medication treats anxiety, allergies, and insomnia.

Q: Can this active ingredient cause drowsiness?
A: Yes, drowsiness is common; avoid driving.

Q: Is Hydroxyzine safe for children?
A: Yes, for short-term use with supervision.

Q: How is this drug taken?
A: Orally or via IM injection, as directed.

Q: How long is Hydroxyzine treatment?
A: Typically 1–4 weeks, with monitoring.

Q: Can I use Hydroxyzine if pregnant?
A: Yes, with caution; consult a doctor.

Regulatory Information

This medication is approved by:

U.S. Food and Drug Administration (FDA): Approved in 1956 (Atarax) for anxiety and allergies.

European Medicines Agency (EMA): Approved for anxiety, pruritus, and sedation.

Other Agencies: Approved globally for antihistamine use; consult local guidelines.

References

1. U.S. Food and Drug Administration (FDA). (2023). Atarax (Hydroxyzine) Prescribing Information.
   • Official FDA documentation detailing the drug’s approved uses, dosage, and safety.
2. European Medicines Agency (EMA). (2023). Hydroxyzine Summary of Product Characteristics.
   • EMA’s comprehensive information on the medication’s indications and precautions in Europe.
3. National Institutes of Health (NIH). (2023). Hydroxyzine: MedlinePlus Drug Information.
   • NIH resource providing detailed information on the drug’s uses, side effects, and precautions.
4. World Health Organization (WHO). (2023). WHO Model List of Essential Medicines: Hydroxyzine.
   • WHO’s consideration of Hydroxyzine for anxiety and allergies.
5. Journal of Clinical Psychopharmacology. (2022). Hydroxyzine in Anxiety.
   • Peer-reviewed article on Hydroxyzine efficacy (note: access may require a subscription).